Development of a Core Outcome Set for Therapeutic Studies in Eosinophilic Esophagitis (COREOS): An International Multidisciplinary Consensus

on behalf of the COREOS Collaborators, COREOS Collaborators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)748-755
Number of pages8
JournalGastroenterology
Volume161
Issue number3
DOIs
StatePublished - Sep 2021

Funding

FundersFunder number
Novartis
Bristol-Myers Squibb
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Dr. Falk Pharma
Sanofi
Glaxo Smith Kline
Eli Lilly and Company
Reckitt Benckiser
National Peanut Board
Shire
GlaxoSmithKline
Bayer
AstraZeneca
AstraZeneca
Shire/Takeda
UpToDate
Dr. Falk Pharma
Medtronic
Nutricia, Norgine, SST
Celgene
Nestlé Nutrition Institute
Receptos
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung32003B_160115/1, 32473B_185008

    Cite this